Latest market price
25.87
-1.36-4.99%
OverviewShort InterestFilings
BEAMQT40Beam Therapeutics Inc.·NASDAQ
25.87-4.99%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 16, 20264Statement of changes in beneficial ownership
Oct 02, 20264Statement of changes in beneficial ownership
Sep 25, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 04, 202610-QQuarterly report
Aug 04, 20268-KCurrent report
Jul 29, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 08, 20268-KCurrent report
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
May 07, 20268-KCurrent report
May 07, 202610-QQuarterly report
Apr 29, 2026SC 13GBeneficial ownership statement (passive)
Apr 17, 2026ARSAnnual report to shareholders
Apr 17, 2026DEF 14ADefinitive proxy statement
Apr 17, 2026DEFA14AAdditional proxy soliciting materials
#1 / 25 of 323
Page
▼
/ 13